Enabling drug delivery
to the brain

Breakthrough in Brain Drug Delivery

Backed by over 15 years of academic research, this innovative technology enables non-invasive delivery of therapeutics to targeted areas of the brain.

Safety

Our real-time dosimetry solution ensures safe disruption of the blood-brain barrier using focused ultrasound for repeated treatments.

Accuracy

Based on state-of-the art neuro-navigation solution, our system ensures precise targeting in the brain.

Multiple targets and volumes

Leveraging our medical robot technology, our platform enables treatment of multiple targets and large volume in a single session.

Our leadership team

Meet the talented individuals behind our groundbreaking medical device that aims to enhance drug delivery to the brain.

Benoit Larrat, PhD.

Founder, CEO

Anthony Novell, PhD.

Founder, CSO

Joseph André, PhD.

COO

Fabienne Betting

CTO

Meet our team

Our investors

From the origin, TheraSonic has grown amongst leaders and innovators in their respective field. TheraSonic is proud to includes CEA investissement, Healthtech venture studio M2care, as well as Gustave Roussy Transfert as their first investors and partners.

Our latest news

  • V&V Manager

    TheraSonic is an innovative company in the field of medical devices. We are currently looking for a Validation and Verification Manager to join our dynamic team and contribute to the development of our therapeutic agent delivery device for…

    Read more: V&V Manager

They support us

Skip to content